AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 154 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $926,000 | +24.1% | 98,352 | +1.0% | 0.00% | – |
| Q2 2020 | $746,000 | +17.1% | 97,406 | -5.6% | 0.00% | – |
| Q1 2020 | $637,000 | -13.3% | 103,192 | +70.9% | 0.00% | – |
| Q4 2019 | $735,000 | -2.0% | 60,374 | -7.0% | 0.00% | – |
| Q3 2019 | $750,000 | +15.9% | 64,898 | +0.2% | 0.00% | – |
| Q2 2019 | $647,000 | -28.7% | 64,741 | -8.0% | 0.00% | – |
| Q1 2019 | $907,000 | -1.8% | 70,366 | +15.8% | 0.00% | – |
| Q4 2018 | $924,000 | -27.9% | 60,762 | -5.2% | 0.00% | – |
| Q3 2018 | $1,281,000 | -52.8% | 64,100 | -53.9% | 0.00% | -100.0% |
| Q2 2018 | $2,712,000 | -15.8% | 139,030 | -13.0% | 0.00% | 0.0% |
| Q1 2018 | $3,220,000 | +294.1% | 159,853 | +159.1% | 0.00% | – |
| Q4 2017 | $817,000 | -13.2% | 61,684 | +20.9% | 0.00% | – |
| Q3 2017 | $941,000 | +6.6% | 51,002 | +6.3% | 0.00% | – |
| Q2 2017 | $883,000 | -70.7% | 47,992 | -64.1% | 0.00% | -100.0% |
| Q1 2017 | $3,011,000 | -34.4% | 133,537 | +1.3% | 0.00% | -50.0% |
| Q4 2016 | $4,587,000 | +149.6% | 131,783 | +75.6% | 0.00% | +100.0% |
| Q3 2016 | $1,838,000 | -16.1% | 75,028 | -18.0% | 0.00% | 0.0% |
| Q2 2016 | $2,190,000 | -18.5% | 91,538 | -20.3% | 0.00% | 0.0% |
| Q1 2016 | $2,686,000 | -29.0% | 114,784 | -8.4% | 0.00% | 0.0% |
| Q4 2015 | $3,782,000 | -93.0% | 125,287 | -90.8% | 0.00% | -95.7% |
| Q3 2015 | $54,091,000 | -48.0% | 1,361,508 | -9.6% | 0.02% | -42.5% |
| Q2 2015 | $104,072,000 | -42.9% | 1,506,359 | -54.8% | 0.04% | +14.3% |
| Q1 2015 | $182,184,000 | +332.9% | 3,333,002 | +237.6% | 0.04% | +118.8% |
| Q4 2014 | $42,083,000 | +131409.4% | 987,383 | +97757.6% | 0.02% | – |
| Q3 2014 | $32,000 | -17.9% | 1,009 | -46.9% | 0.00% | – |
| Q2 2014 | $39,000 | -81.6% | 1,899 | -82.6% | 0.00% | – |
| Q1 2014 | $212,000 | -20.0% | 10,925 | 0.0% | 0.00% | – |
| Q4 2013 | $265,000 | +12.3% | 10,925 | -0.6% | 0.00% | – |
| Q3 2013 | $236,000 | -3.7% | 10,991 | 0.0% | 0.00% | – |
| Q2 2013 | $245,000 | – | 10,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |